Activity of paraoxonase 1 and lipid profile in healthy children

Physiological Research

Volumn 56, Issue 3, 2007, Pages 351-357

  Sumegova K ^a   Nagyova Z ^b   Waczulikova I ^c   Zitnanova I ^a   Ďuračková, Zdeňka ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b Paediatric Department   (Slovakia)

^c Physics and Informatics   (Slovakia)

Author keywords

Atherosclerosis; HDL; Lipid peroxides; Paraoxonase 1; TEAC

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PON1 PROTEIN, HUMAN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; BLOOD; CHILD; FEMALE; HUMAN; LIPID METABOLISM; MALE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY;

ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; CHILD; CHOLESTEROL, HDL; FEMALE; HUMANS; LIPID METABOLISM; MALE; OXIDATIVE STRESS; TRIGLYCERIDES;

EID: 34547227691     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. AHMED Z, RAVANDI A, MAGUIRE GF, EMILI A, DRAGANOV DI, LA DU BN, KUKSIS A, CONNELLY PW: Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor. J Biol Chem 276: 24473-24481, 2001.
2. AVIRAM M, HARDAK E, VAYA J, MAHMOOD S, MILO S, HOFFMAN A, BILLICKE S, DRAGANOV D, ROSENBLAT M: Human serum paraoxonase (PON) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 101: 2510-2517, 2000.
3. AVIRAM M, ROSENBLAT M: Paraoxonase 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 37: 1304-1316, 2004.
4. BELTOWSKI J, WÓJCICKA G, MARCINIAK A: Species- and substrate-specific stimulation of human plasma paraoxonase 1 (PON1) activity by high chloride concentration. Acta Biochem Polon 49: 927-936, 2002.
5. ECE A, ATAMER Y, GURKAN F, DAVUTOGLU M, BILICI M, TUTANC M, GUNES A: Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure. Pediatr Nephrol 27: 1279-1284, 2005.
6. FRIEDEWALD WT, LEVY RI, FREDERICKSON DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18: 449-502, 1972.
7. FUHRMAN B, VOLKOVA N, AVIRAM M: Paraoxonase 1 (PON1) is present in postprandial chylomicrons. Atherosclerosis 180: 55-61, 2005.
8. GAN KN, SMOLEN A, ECKERSON HW and LA DU BN: Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 19: 100-106, 1991.
9. GORNICKA G, BELTOWSKI J, WOJCICKA G, JAMROZ A: Serum paraoxonase activity, total antioxidant potential and lipid peroxidation products in children with bronchial asthma exacerbation. Wiad Lek 55: 257-263, 2002.
10. JAMES RW, DEAKIN SP: The importance of high-density lipoproteins for paraoxonase-1 secretion, stability and activity. Free Radic Biol Med 37: 1986-1994, 2004.
11. MACKNESS B, DURRINGTON PN, MACKNESS MI: Human serum paraoxoanse. Gen Pharmacol 3: 329-336, 1998.
12. MACKNESS B, MACKNESS MI, DURRINGTON PN, ARROL S, EVANS AE, MCMASTER D, FERRIÈRES J, RUIDAVETS JB, WILLIAMS NR, HOWARD AN: Paraoxonase activity in two healthy populations with differing rates of coronary heart disease. Eur J Clin Invest 30: 4-10, 2000.
13. MACKNESS MI, HARTY D, BHATNAGAR D, WINOCOUR PH, ARROL S, ISHOLA M, DURRINGTON PN: Serum paraoxonase activity in familial hypercholesterolemia and insulin-dependent diabetes mellitus. Atherosclerosis 86: 193-199, 2001.
14. MACKNESS B, DURRINGTON PN, BOULTON AJM, HINE D, MACKNESS MI: Serum paraoxonase activity in patients with type I diabetes compared to healthy controls. Eur J Clin Invest 32: 259-264, 2002a.
15. MACKNESS MI, MACKNESS BM, DURRINGTON PN: Paraoxonase and coronary heart disease. Atheroscler Suppl 3 (4): 49-55, 2002b.
16. NAGYOVÁ Z: Cholesterol - is it necessary to monitor in children? (in Slovak) Child 26, 2004.
17. RE R, PELLEGRINI N, PROTEGGENTE A, PANNALA A, YANG M, RICE-EVANS C: Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26: 1231-1237, 1999.
18. SHIH DM, XIA YR, MILLER E, CATELLIANI LW, SUBBANAGOUNDER G, CHEROUTRE H, FAULL KF, BERLINER JA, WITZTUM JL, LUSIS AJ: Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem 275: 17527-17535, 2000.
19. TOMÁS M, SENTÍ M, GARCÍA-FARIA F, VILA J, TORRENTS A, COVAS M, MARRUGAT J: Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 20: 2113-2119, 2000.